Chatham Capital Group’s Pfizer PFE Stock Holding History

Chatham Capital Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$690K	Sell	28,651 -99	-0.3%	-$2.59K	0.09%	149
2026 Q1	$807K	Hold	28,750	–	–	0.12%	141
2025 Q4	$716K	Sell	28,750 -295	-1%	-$7.44K	0.1%	142
2025 Q3	$740K	Buy	29,045 +155	+0.5%	+$3.83K	0.11%	143
2025 Q2	$700K	Buy	28,890 +1,000	+4%	+$23.3K	0.11%	140
2025 Q1	$707K	Sell	27,890 -290	-1%	-$7.59K	0.12%	138
2024 Q4	$748K	Sell	28,180 -484	-2%	-$13.1K	0.12%	137
2024 Q3	$830K	Sell	28,664 -680	-2%	-$19.8K	0.14%	132
2024 Q2	$821K	Sell	29,344 -2,250	-7%	-$61.9K	0.14%	130
2024 Q1	$877K	Buy	31,594 +1,237	+4%	+$34.3K	0.16%	129
2023 Q4	$874K	Sell	30,357 -1,273	-4%	-$38.5K	0.18%	122
2023 Q3	$1.05M	Buy	31,630 +161	+0.5%	+$5.69K	0.23%	113
2023 Q2	$1.15M	Buy	31,469 +25	+0.1%	+$973	0.24%	111
2023 Q1	$1.28M	Sell	31,444 -200	-0.6%	-$8.64K	0.29%	106
2022 Q4	$1.62M	Sell	31,644 -399	-1%	-$19.1K	0.38%	86
2022 Q3	$1.4M	Sell	32,043 -57	-0.2%	-$2.77K	0.34%	89
2022 Q2	$1.68M	Sell	32,100 -331	-1%	-$16.9K	0.38%	81
2022 Q1	$1.68M	Sell	32,431 -1,849	-5%	-$95.9K	0.32%	85
2021 Q4	$2.02M	Buy	34,280 +510	+2%	+$25.3K	0.37%	72
2021 Q3	$1.45M	Buy	33,770 +1,166	+4%	+$51.7K	0.28%	89
2021 Q2	$1.28M	Buy	32,604 +3,789	+13%	+$147K	0.25%	98
2021 Q1	$1.04M	Buy	28,815 +381	+1%	+$13.5K	0.22%	107
2020 Q4	$1.05M	Sell	28,434 -702	-2%	-$25.8K	0.24%	101
2020 Q3	$1.01M	Sell	29,136 -2,107	-7%	-$73.9K	0.25%	87
2020 Q2	$969K	Buy	31,243 +106	+0.3%	+$3.6K	0.25%	91
2020 Q1	$964K	Sell	31,137 -783	-2%	-$26.7K	0.28%	82
2019 Q4	$1.19M	Sell	31,920 -759	-2%	-$27K	0.29%	85
2019 Q3	$1.11M	Sell	32,679 -406	-1%	-$14.8K	0.28%	87
2019 Q2	$1.36M	Hold	33,085	–	–	0.34%	79
2019 Q1	$1.33M	Buy	33,085 +316	+1%	+$12.7K	0.34%	82
2018 Q4	$1.36M	Buy	32,769 +256	+0.8%	+$10.6K	0.38%	69
2018 Q3	$1.36M	Sell	32,513 -356	-1%	-$13.7K	0.34%	72
2018 Q2	$1.13M	Buy	32,869 +1,041	+3%	+$35.6K	0.3%	77
2018 Q1	$1.07M	Sell	31,828 -9,383	-23%	-$323K	0.29%	75
2017 Q4	$1.42M	Hold	41,211	–	–	0.39%	59
2017 Q3	$1.4M	Sell	41,211 -2,686	-6%	-$86.3K	0.4%	58
2017 Q2	$1.4M	Sell	43,897 -1,924	-4%	-$60.7K	0.39%	58
2017 Q1	$1.49M	Buy	45,821 +2,556	+6%	+$80.6K	0.42%	51
2016 Q4	$1.33M	Hold	43,265	–	–	0.39%	61
2016 Q3	$1.39M	Sell	43,265 -632	-1%	-$21.1K	0.44%	46
2016 Q2	$1.47M	Buy	43,897 +422	+1%	+$13.5K	0.45%	44
2016 Q1	$1.22M	Buy	43,475 +1,212	+3%	+$34.6K	0.39%	52
2015 Q4	$1.29M	Buy	42,263 +105	+0.2%	+$3.3K	0.42%	53
2015 Q3	$1.26M	Sell	42,158 -316	-0.7%	-$10.1K	0.42%	47
2015 Q2	$1.35M	Buy	42,474 +190	+0.4%	+$6.19K	0.38%	55
2015 Q1	$1.4M	Buy	42,284 +2,000	+5%	+$63.6K	0.41%	51
2014 Q4	$1.19M	Buy	40,284 +6,224	+18%	+$178K	0.36%	54
2014 Q3	$956K	Buy	+34,060	New	+$956K	0.3%	69
2014 Q2	–	Sell	-7,246	Closed	-$221K	–	108
2014 Q1	$221K	Sell	7,246 -1,581	-18%	-$47.1K	0.09%	104
2013 Q4	$257K	Hold	8,827	–	–	0.11%	101
2013 Q3	$241K	Hold	8,827	–	–	0.11%	101
2013 Q2	$235K	Buy	+8,827	New	+$244K	0.11%	105

Other funds holding PFE

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

ORIO

Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return

WAM

Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Chatham Capital Group's PFE Position: Q2 2026 in Review

Chatham Capital Group reduced its Pfizer (PFE) stake by 0.34% in Q2 2026, selling an estimated $2.59K and leaving 28,651 shares worth $690K. The position accounts for 0.09% of the portfolio, ranked #149.

Chatham Capital Group first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.02M in Q4 2021. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Chatham Capital Group held 28,651 shares of Pfizer worth $690K as of Q2 2026.
Chatham Capital Group sold 99 Pfizer shares in Q2 2026, an estimated $2.59K.
Pfizer made up 0.09% of Chatham Capital Group's portfolio in Q2 2026, its #149 holding.
Chatham Capital Group first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
Chatham Capital Group's Pfizer position peaked at $2.02M in Q4 2021.
491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Chatham Capital Group's 13F filing for Q2 2026, filed 13 Jul 2026.